The Thunderbolt device from California-based Penumbra uses modulated aspiration to detect and remove blood clots. Back in January, Boston Scientific agreed to acquire Penumbra for approximately $14.5 billion.
Researchers tracked real-world data from more than 140 patients who originally received a transcatheter heart valve from Edwards Lifesciences, Medtronic or Boston Scientific.
The company hopes this new round of funding from private-equity investors will help its home-based care model flourish and reach more patients than ever before.
Even as TAVR continues to build momentum as the go-to treatment option for many patients, researchers are keeping a close eye on the long-term safety and effectiveness of SAVR.
A group of interventional cardiologists, neurologists and vascular surgeons successfully petitioned Medicare to change its coverage determination for carotid stenting procedures.
Interventional cardiologist Alfred G. Valles, MD, was 50 years old at the time of the accident. According to colleagues, he "strived daily to achieve his vision for world-class care."
David Hur, MD, director of structural heart disease/interventional imaging at the VA Connecticut Healthcare System, and an assistant professor of medicine at Yale, explains the technical challenges encountered in cardiac computed tomography (CT) and how to overcome them.
Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.
